CIBC Private Wealth Group
TENX icon

CIBC Private Wealth Group’s Tenax Therapeutics TENX Stock Holding History

CIBC Private Wealth Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-343
Closed -$1.09K – 3292
2024
Q2 		$1.09K Hold
343
– – ﹤0.01% 2887
2024
Q1 		$1.31K Buy
+343
New +$2.63K ﹤0.01% 2825
2018
Q1 		– Hold
0
– – – 2065
2017
Q4 		– Hold
0
– – – 1983

Other funds holding TENX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIBC Private Wealth Group's TENX Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of Tenax Therapeutics (TENX) in Q3 2024, closing a stake of 343 shares — an estimated $1.09K sold.

CIBC Private Wealth Group first reported a position in TENX in Q1 2024 and held it in 2 quarters. The position peaked at $1.31K in Q1 2024. 19 funds tracked by Wall St. Rank hold TENX as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining Tenax Therapeutics position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 343 Tenax Therapeutics shares in Q3 2024, an estimated $1.09K.
  • CIBC Private Wealth Group first reported a position in Tenax Therapeutics in Q1 2024 and held it in 2 quarters.
  • CIBC Private Wealth Group's Tenax Therapeutics position peaked at $1.31K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.